查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451431

2024-2032 年按涂层、药物、支架平台、生成、应用、最终用户和地区分類的药物洗脱支架市场报告

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球药物洗脱支架市场规模达83亿美元。展望未来， IMARC Group预计到2032年市场规模将达到137亿美元，2024-2032年复合年增长率（CAGR）为5.51%。

药物洗脱支架 (DES) 是一种冠状动脉装置，用于在周边或冠状动脉中缓慢释放药物，以阻止细胞增殖并促进健康的血液流动。它由金属支架、聚合物涂层和抗再狭窄药物组成。支架上涂有药物，有助于动脉保持畅通并确保足够的血流。 DES 广泛用于治疗心臟动脉阻塞、防止斑块堆积、血栓并减少反覆血管重建。此支架是微创 (MI) 的，可降低再狭窄率、增强血管癒合并减少长期双重抗血小板治疗的需要。

药物洗脱支架市场趋势：

容易患慢性疾病的老年人口不断增加是推动市场成长的关键因素之一。 DES 广泛用于患有动脉疾病的高风险患者，因为支架有助于减少冠状动脉绕道手术等侵入性手术的需求。此外，由于大众不健康的饮食习惯、缺乏体力活动和久坐的生活方式，心血管疾病的盛行率不断上升，有利于市场的成长。此外，各种技术进步，例如生物可吸收支架的推出，正在推动市场成长。这些支架很容易在体内溶解，并降低支架血栓的风险。与此一致的是，无聚合物涂层支架的广泛采用对市场成长产生了积极影响。这些支架表现出更高的载药能力和更快的药物洗脱速率。其他因素，包括异常心律、心臟衰竭和心臟病发作的发病率上升，以及大众对 MI 技术的需求不断增加，预计将推动市场成长。

本报告回答的关键问题

  • 2023年全球药物洗脱支架市场规模有多大？
  • 2024-2032年全球药物洗脱支架市场的预期成长率是多少？
  • 推动全球药物洗脱支架市场的关键因素是什么？
  • COVID-19对全球药物洗脱支架市场有何影响？
  • 基于涂层的全球药物洗脱支架市场格局如何？
  • 基于支架平台的全球药物洗脱支架市场区隔如何？
  • 根据应用，全球药物洗脱支架市场的细分如何？
  • 根据最终用户，全球药物洗脱支架市场的细分如何？
  • 全球药物洗脱支架市场的重点区域有哪些？
  • 全球药物洗脱支架市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球药物洗脱支架市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：按涂层

  • 聚合物基涂料
    • 市场走向
    • 市场预测
  • 无聚合物涂层
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依药品分类

  • 西罗莫司
    • 市场走向
    • 市场预测
  • 紫杉醇
    • 市场走向
    • 市场预测
  • 佐他莫司
    • 市场走向
    • 市场预测
  • 依维莫司
    • 市场走向
    • 市场预测
  • 比奥莫司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按支架平台

  • 不銹钢
    • 市场走向
    • 市场预测
  • 钴铬合金
    • 市场走向
    • 市场预测
  • 铂铬
    • 市场走向
    • 市场预测
  • 镍钛诺
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按世代

  • 第一代
    • 市场走向
    • 市场预测
  • 第二代
    • 市场走向
    • 市场预测
  • 第三代
    • 市场走向
    • 市场预测
  • 第四代
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按应用

  • 冠状动脉疾病
    • 市场走向
    • 市场预测
  • 週边动脉疾病
    • 市场走向
    • 市场预测

第 11 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 12 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 13 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 14 章：价值链分析

第 15 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 16 章：价格分析

第17章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd.
    • Biotronik
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC (Cook Group Incorporated)
    • Lepu Medical Technology (Beijing) Co. Ltd.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Sino Medical Sciences Technology Inc.
    • Terumo Corporation
Product Code: SR112024A4815

The global drug-eluting stents market size reached US$ 8.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.51% during 2024-2032.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

Drug-Eluting Stents Market Trends:

The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

Polymer Based Coating

Polymer Free Coating

Breakup by Drug:

Sirolimus

Paclitaxel

Zotarolimus

Everolimus

Biolimus

Others

Breakup by Stent Platform:

Stainless-steel

Cobalt-Chromium

Platinum-Chromium

Nitinol

Others

Breakup by Generation:

1st Generation

2nd Generation

3rd Generation

4th Generation

Breakup by Application:

Coronary Artery Disease

Peripheral Artery Disease

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Key Questions Answered in This Report

  • 1. What was the size of the global drug-eluting stents market in 2023?
  • 2. What is the expected growth rate of the global drug-eluting stents market during 2024-2032?
  • 3. What are the key factors driving the global drug-eluting stents market?
  • 4. What has been the impact of COVID-19 on the global drug-eluting stents market?
  • 5. What is the breakup of the global drug-eluting stents market based on the coating?
  • 6. What is the breakup of the global drug-eluting stents market based on the stent platform?
  • 7. What is the breakup of the global drug-eluting stents market based on the application?
  • 8. What is the breakup of the global drug-eluting stents market based on the end user?
  • 9. What are the key regions in the global drug-eluting stents market?
  • 10. Who are the key players/companies in the global drug-eluting stents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug-Eluting Stents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Coating

  • 6.1 Polymer Based Coating
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polymer Free Coating
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug

  • 7.1 Sirolimus
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Paclitaxel
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Zotarolimus
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Everolimus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Biolimus
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Stent Platform

  • 8.1 Stainless-steel
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cobalt-Chromium
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Platinum-Chromium
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nitinol
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Generation

  • 9.1 1st Generation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 2nd Generation
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 3rd Generation
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 4th Generation
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Coronary Artery Disease
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Peripheral Artery Disease
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by End User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Ambulatory Surgical Centers
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia-Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 Abbott Laboratories
      • 17.3.1.1 Company Overview
      • 17.3.1.2 Product Portfolio
      • 17.3.1.3 Financials
      • 17.3.1.4 SWOT Analysis
    • 17.3.2 B. Braun Melsungen AG
      • 17.3.2.1 Company Overview
      • 17.3.2.2 Product Portfolio
      • 17.3.2.3 SWOT Analysis
    • 17.3.3 Biosensors International Group Ltd.
      • 17.3.3.1 Company Overview
      • 17.3.3.2 Product Portfolio
    • 17.3.4 Biotronik
      • 17.3.4.1 Company Overview
      • 17.3.4.2 Product Portfolio
      • 17.3.4.3 SWOT Analysis
    • 17.3.5 Boston Scientific Corporation
      • 17.3.5.1 Company Overview
      • 17.3.5.2 Product Portfolio
      • 17.3.5.3 Financials
      • 17.3.5.4 SWOT Analysis
    • 17.3.6 Cardinal Health Inc.
      • 17.3.6.1 Company Overview
      • 17.3.6.2 Product Portfolio
      • 17.3.6.3 Financials
      • 17.3.6.4 SWOT Analysis
    • 17.3.7 Cook Medical LLC (Cook Group Incorporated)
      • 17.3.7.1 Company Overview
      • 17.3.7.2 Product Portfolio
      • 17.3.7.3 SWOT Analysis
    • 17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
      • 17.3.8.1 Company Overview
      • 17.3.8.2 Product Portfolio
      • 17.3.8.3 Financials
    • 17.3.9 Medtronic plc
      • 17.3.9.1 Company Overview
      • 17.3.9.2 Product Portfolio
      • 17.3.9.3 Financials
      • 17.3.9.4 SWOT Analysis
    • 17.3.10 MicroPort Scientific Corporation
      • 17.3.10.1 Company Overview
      • 17.3.10.2 Product Portfolio
    • 17.3.11 Sino Medical Sciences Technology Inc.
      • 17.3.11.1 Company Overview
      • 17.3.11.2 Product Portfolio
    • 17.3.12 Terumo Corporation
      • 17.3.12.1 Company Overview
      • 17.3.12.2 Product Portfolio
      • 17.3.12.3 Financials
      • 17.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
  • Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2023
  • Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2023
  • Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2023
  • Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2023
  • Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2023
  • Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2023
  • Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2023
  • Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
  • Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
  • Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2024-2032
  • Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2024-2032
  • Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2024-2032
  • Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2024-2032
  • Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
  • Table 10: Global: Drug-Eluting Stents Market: Key Players